I understand the logic of how ALT 1103 has / may have an affect of reducing IGF-1 being a growth hormone, but I struggle to understand how this same serum/drug may have benefits for other health conditions such as diabetes / breast cancer/
If a drug developed is proven to minimize the cell which causes organ growth(in primates), how is this related (where is the relationship) to the other benefits as stated above.
Any input would be Greatly appreciated
- Forums
- ASX - By Stock
- PER
- medical benefits alt 1103
medical benefits alt 1103
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $75.73M |
Open | High | Low | Value | Volume |
8.4¢ | 8.5¢ | 8.4¢ | $31.98K | 379.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 262571 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 119843 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 262571 | 0.084 |
1 | 10000 | 0.083 |
2 | 193598 | 0.082 |
2 | 49037 | 0.081 |
6 | 30108 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 119843 | 1 |
0.088 | 13868 | 1 |
0.089 | 14285 | 1 |
0.090 | 546175 | 2 |
0.091 | 108000 | 1 |
Last trade - 14.51pm 19/06/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online